Study at a glance
What was studied?
This review compares gut, lung and skin barrier studies in cells, mice and people. Researchers measured passage of tracked substances, water loss, resistance to an electrical current and proteins at connections between cells. These tests describe different barrier properties.
What was found?
Some mouse and cell experiments showed worse barrier function with low vitamin D supply or loss of its receptor, the protein enabling cells to respond. In one gut model, mice whose receptor gene was deleted already had more passage of a tracked substance before injury. A dietary lung study did not show a clear initial barrier defect. Active hormone reduced water loss in mice with inflamed skin. Human trials did not clearly establish the expected barrier benefit.
What does it mean?
Effects depended on tissue, injury and measurement. A junction protein change is not automatically better exclusion of harmful material. More inflammatory cells do not by themselves prove leakage.
What are the limits?
Genetic receptor loss, dietary deficiency and active-hormone treatment are different experiments. The findings do not establish that all low vitamin D states cause leakage or that supplements prevent infection. Research amounts are not personal treatment doses.
Read the full article below ↓Vitamin D signalling means cells responding to the active vitamin D hormone. It can affect barriers formed by the lining cells of the gut, lung and skin. The findings depend on the tissue, injury and measurement. Low dietary supply, deleting the receptor protein needed for cells to respond and treatment with active hormone are different experiments. Human trials have not clearly established the benefits suggested by some models. The detailed counterpart is Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Full Evidence Review.
What does a barrier measurement show?
Epithelial cells are lining cells at interfaces with the environment. A tracer is a substance researchers track to measure passage through a barrier. They also measure water loss through skin, resistance to an electrical current or proteins at junctions between cells. These tests measure different properties. More of one protein does not automatically mean a better barrier.
The review compared seven central studies and a supporting airway-cell experiment. It asked about integrity across tissues and failure during infection or inflammation. The results do not supply one universal measure of barrier health.
What happened in gut experiments?
In Li’s mouse study, the receptor-knockout mice, whose receptor gene was deleted, already had more tracer passage before injury. Dietary deficiency and receptor loss both worsened colitis, inflammation of the colon, after chemical injury and increased tracer leakage. Removing this receptor throughout the body does not isolate an effect in lining cells or reproduce ordinary dietary deficiency. Different treatment groups also used different injury schedules. The experiments did not show that supplements prevent human colitis. [1]
Zhang’s study found that the receptor directly regulates claudin-2, a protein involved in pores at cell junctions. Increasing it cannot automatically be called tighter exclusion of pathogens. Changing a protein and changing the overall passage through a barrier are different results. [4]
In a Campylobacter experiment, calcitriol helped preserve selected properties of cell layers and reduced bacterial movement across them. Calcitriol is the active hormone. Pretreated laboratory layers and altered mice do not establish prevention or treatment of infection in people. [5]
The physiological setting is Vitamin D and Gut. The detailed intestinal review is Intestinal VDR, Barrier Function and Microbial Metabolism: Evidence Review. This comparison does not turn their tissue-specific findings into a universal result.
Were skin and lung results the same?
Calcitriol applied to mouse skin reduced water loss through the skin and improved restriction of a tracer in a dermatitis model, which causes inflamed skin. Healthy skin did not show the same benefit, and a lower dose did not reproduce it. This was not an oral supplement trial or human eczema treatment. [2]
In Gorman’s dietary-deficiency study, the number of inflammatory cells in the lungs changed without a clear initial defect on the tested barrier measurements. The lungs were not infected or otherwise challenged. The lack of a clear difference does not exclude defects after a particular injury, but it argues against assuming that all deficiency causes spontaneous leakage. [3]
A separate airway-cell study found altered resistance and tracer passage with active hormone, plus partial protection against an inflammatory signal. That result concerns a cell model, not improved breathing or fewer infections. The experiments can differ because their systems and exposures differ. [8]
These are separate aspects of Vitamin D and Skin and Vitamin D and Lung Function. Skin water loss is not the same measurement as airway-fluid protein or intestinal tracer passage.
What did human trials show?
Raftery assigned twenty-seven adults with Crohn’s disease by chance to vitamin D or placebo, an inactive comparison. Crohn’s disease causes gut inflammation; these participants had relatively quiet disease. Vitamin D status increased, but the direct comparisons of probe passage through the gut lining between groups did not establish benefit. A change within one group and no significant change within the other do not themselves prove a treatment difference. No new disease flares in two small groups do not prove that the treatment prevented flares. [6]
A longer trial analysis involving 175 people who had growths called adenomas removed from the colon found no clear effect on selected antibodies related to bacterial exposure. These were indirect markers, not direct measurements of all barrier passage. The result does not prove that vitamin D has no barrier effect in any setting. [7]
What is the practical interpretation?
The effects depended on the tissue and injury. Evidence of benefit in people remains limited. Vitamin D and Mucosal Defence concerns related microbial defence, which is not identical to physical barrier function. The studies do not establish that all low vitamin D states cause leakage or that supplements reliably prevent infection or inflammation. The forms and amounts tested do not establish personal doses or blood targets.
Primary sources
[1] Li Y et al. Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway. Frontiers in pharmacology. 2024;15:1421577. DOI: 10.3389/fphar.2024.1421577. PMID: 39130644.
[2] Umehara Y et al. Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. International journal of molecular sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.
[3] Gorman S et al. Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity. Physiological reports. 2017;5(15):e13371. DOI: 10.14814/phy2.13371. PMID: 28774952.
[4] Zhang YG et al. Tight junction CLDN2 gene is a direct target of the vitamin D receptor. Scientific reports. 2015;5:10642. DOI: 10.1038/srep10642. PMID: 26212084.
[5] Lobo de Sá FD et al. Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni. International journal of molecular sciences. 2021;22(16):8872. DOI: 10.3390/ijms22168872. PMID: 34445577.
[6] Raftery T et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. DOI: 10.1177/2050640615572176. PMID: 26137304.
[7] Vermandere K et al. Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Patients with Colon Adenoma: A Randomized Clinical Trial. Cancer prevention research (Philadelphia, Pa.). 2021;14(3):393-402. DOI: 10.1158/1940-6207.CAPR-20-0461. PMID: 33229339.
[8] Rybakovsky E et al. Calcitriol modifies tight junctions, improves barrier function, and reduces TNF-α-induced barrier leak in the human lung-derived epithelial cell culture model, 16HBE 14o. Physiological reports. 2023;11(7):e15592. DOI: 10.14814/phy2.15592. PMID: 37038908.
Related reading
Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice
Here, we investigated the effects of calcitriol, an active form of vitamin D3, on an NC/Nga mouse model of atopic dermatitis.
Original paper ↗Read more →Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Both effects were concentration dependent and active out to 168 h post‐treatment.
Original paper ↗Read more →Tight junction CLDN2 gene is a direct target of the vitamin D receptor
The breakdown of the intestinal barrier is a common manifestation of many diseases.
Original paper ↗Read more →Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni
The aim was to evaluate the relationship between epithelial barrier disruption, mucosal immune activation, and vitamin D (VD) treatment during C.
Original paper ↗Read more →Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Full Evidence Review
Gut, lung and skin studies compared: what vitamin D signalling reveals about barrier failure, and what human trials do and do not establish.
Read more →Non-Skeletal Roles of Vitamin D in Skin, Gut, and Cardiovascular Disease: Focus on Epithelial Barrier Function and Immune Regulation in Chronic Disease
Vitamin D is increasingly recognized as a key regulator of epithelial barrier integrity and mucosal immune homeostasis, with implications extending far beyond skeletal health.
Original paper ↗Read more →Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Full Evidence Review
Review mouse calcitriol and rat receptor experiments on skin permeability, immune markers and keratinocyte maintenance, with limits on clinical claims.
Read more →Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Study Summary
Summary of animal skin-barrier experiments: selective calcitriol responses, receptor-dependent maintenance and the limits of human treatment claims.
Read more →Vitamin D Roles Across Developmental Stages in Pediatric Pneumonia: Linking Genetics, Microbiome, Maternal Status and Immunity
Peer‐reviewed articles, including observational studies, randomized controlled trials, and reviews, were screened.
Original paper ↗Read more →Combined effect of vitamin C and vitamin D3 on intestinal epithelial barrier by regulating Notch signaling pathway
Compared with the control group, the expression level of ZO-1 mRNA in the colon tissue of the high-dose vitamin C group was significantly increased.
Original paper ↗Read more →Distinct roles of short and long thymic stromal lymphopoietin isoforms in house dust mite-induced asthmatic airway epithelial barrier disruption
Loss of airway epithelial integrity contributes significantly to asthma pathogenesis.
Original paper ↗Read more →The epithelial barrier: a Janus-faced regulator in allergic airway diseases from defense to inflammation
We also evaluate contemporary diagnostic technologies for assessing the epithelial barrier and analyze current therapeutic strategies aimed at its restoration.
Original paper ↗Read more →Intestinal VDR, Barrier Function and Microbial Metabolism: Full Evidence Review
Examine vitamin D receptor experiments on intestinal barriers and microbial metabolism, alongside human trials of permeability, immune markers and microbiota.
Read more →Intestinal VDR, Barrier Function and Microbial Metabolism: Study Summary
Summary of intestinal VDR, Notch-related barrier responses and microbial metabolism, with direct human permeability and microbiota trial findings.
Read more →Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
However, its role in sepsis-induced intestinal barrier dysfunction has not been investigated.
Original paper ↗Read more →The Relationship between Low Serum Vitamin D Levels and Altered Intestinal Barrier Function in Patients with IBS Diarrhoea Undergoing a Long-Term Low-FODMAP Diet: Novel Observations from a Clinical Trial
Decreased serum vitamin D (VD) levels have been associated with gastrointestinal (GI) disorders, including irritable bowel syndrome (IBS).
Original paper ↗Read more →1,25(OH)2D3 deficiency-induced gut microbial dysbiosis degrades the colonic mucus barrier in Cyp27b1 knockout mouse model
The relationship between disturbances of the gut microbiota and 1,25(OH)2D3 deficiency has been established both in humans and animal models with a vitamin D poor diet or a lack of sun exposure.
Original paper ↗Read more →Vitamin D strengthens the bladder epithelial barrier by inducing tight junction proteins during E. coli urinary tract infection
Tight junction proteins are pivotal to prevent bacterial invasion of the epithelial barrier.
Original paper ↗Read more →Local nebulization of 1α,25(OH)2D3 attenuates LPS-induced acute lung inflammation
In this study, we investigated if local delivery of vitamin D to the lungs improves vitamin D-mediated anti-inflammatory action in response to acute inflammation without inducing hypercalcemia.
Original paper ↗Read more →Vitamin D Receptor Expression in Dogs
Thirty‐five dogs diagnosed with a chronic enteropathy (CE) and 24 control dogs were prospectively enrolled and duodenal biopsies were evaluated for VDR expression.
Original paper ↗Read more →Molecular mechanism mediating enteric bacterial translocation after severe burn: the role of cystic fibrosis transmembrane conductance regulator
This study aimed to investigate whether CFTR plays a role in both regulating the intestinal barrier and mediating EBT post severe burn, as well as the signaling pathways involved in these processes.
Original paper ↗Read more →Original sources
Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway
Published in Frontiers in pharmacology (2024).
Publication details
[1] Li Y et al. Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway. Frontiers in pharmacology. 2024;15:1421577. DOI: 10.3389/fphar.2024.1421577. PMID: 39130644.
Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice
Here, we investigated the effects of calcitriol, an active form of vitamin D3, on an NC/Nga mouse model of atopic dermatitis.
Publication details
[2] Umehara Y et al. Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. International journal of molecular sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.
Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity
Published in Physiological reports (2017).
Publication details
[3] Gorman S et al. Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity. Physiological reports. 2017;5(15):e13371. DOI: 10.14814/phy2.13371. PMID: 28774952.
Tight junction CLDN2 gene is a direct target of the vitamin D receptor
The breakdown of the intestinal barrier is a common manifestation of many diseases.
Publication details
[4] Zhang YG et al. Tight junction CLDN2 gene is a direct target of the vitamin D receptor. Scientific reports. 2015;5:10642. DOI: 10.1038/srep10642. PMID: 26212084.
Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni
The aim was to evaluate the relationship between epithelial barrier disruption, mucosal immune activation, and vitamin D (VD) treatment during C.
Publication details
[5] Lobo de Sá FD et al. Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni. International journal of molecular sciences. 2021;22(16):8872. DOI: 10.3390/ijms22168872. PMID: 34445577.
Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study
Published in United European gastroenterology journal (2015).
Publication details
[6] Raftery T et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. DOI: 10.1177/2050640615572176. PMID: 26137304.
Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Patients with Colon Adenoma: A Randomized Clinical Trial
Published in Cancer prevention research (Philadelphia, Pa.) (2021).
Publication details
[7] Vermandere K et al. Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Patients with Colon Adenoma: A Randomized Clinical Trial. Cancer prevention research (Philadelphia, Pa.). 2021;14(3):393-402. DOI: 10.1158/1940-6207.CAPR-20-0461. PMID: 33229339.
Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Both effects were concentration dependent and active out to 168 h post‐treatment.
Publication details
[8] Rybakovsky E et al. Calcitriol modifies tight junctions, improves barrier function, and reduces TNF-α-induced barrier leak in the human lung-derived epithelial cell culture model, 16HBE 14o. Physiological reports. 2023;11(7):e15592. DOI: 10.14814/phy2.15592. PMID: 37038908.